Generalized Linear Porokeratosis Treated With Ixekizumab.

Yihe Zheng1, Yunhao Zhu2, Jianjun Qiao1

  • 1Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

The Journal of Dermatology
|December 12, 2025
PubMed
Summary

Ixekizumab effectively treated extensive linear porokeratosis (LP) in a young patient, achieving near-complete lesion clearance. While skin lesions responded well, nail dystrophy showed limited improvement, suggesting targeted therapy potential for refractory LP.